XML 14 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Mar. 31, 2020
Current assets    
Cash and cash equivalents $ 36,558,752 $ 33,654,765
Accounts receivable 34,563,743 30,036,448
Inventories 1,785,379 2,029,406
Prepaid expenses and other current assets 22,189,744 4,264,130
Total current assets 95,097,618 69,984,749
Property, plant and equipment, net 10,514,031 7,896,501
Intangible assets, net 1,832,099 719,722
Goodwill 162,832  
Other assets 5,138,105 6,496,501
TOTAL ASSETS 112,744,685 85,097,473
Current liabilities    
Accounts payable 8,841,163 1,549,255
Other payables and accrued liabilities 3,694,943 512,249
Due to related party   844,716
Income tax payable 334,523 568,830
Short-term bank borrowings 2,237,000 2,032,434
TOTAL LIABILITIES 15,107,629 5,507,484
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY    
Ordinary shares, $0.0005 par value, 90,000,000 shares authorized, 30,481,580 and 25,000,000 shares issued and outstanding, respectively 15,241 12,500
Preferred shares, $0.0005 par value, 10,000,000 shares authorized, 0 shares issued and outstanding
Additional paid-in capital 26,545,384 15,044,002
Statutory surplus reserve 7,622,765 2,064,096
Retained earnings 61,475,891 66,623,204
Accumulated other comprehensive loss (913,621) (4,153,813)
Total Happiness Biotech Group Limited’s shareholders’ equity 94,745,660 79,589,989
Non-controlling interests 2,891,396  
Total shareholders’ equity 97,637,056 79,589,989
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 112,744,685 $ 85,097,473